FDA inspection
AGC Pharma Chemicals Europe, S.L.U.: FDA inspection ending Nov 20, 2023
FDA inspection 1225598 · No Action Indicated (NAI) · Malgrat De Mar
Key facts
| Inspection ID | 1225598 |
|---|---|
| Firm | AGC Pharma Chemicals Europe, S.L.U. |
| FEI number | 3002806459 |
| Address | Cami Pomereda 13 |
| City | Malgrat De Mar |
| Country | Spain |
| Fiscal year | 2024 |
| Inspection end date | Nov 20, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data